IDXX — IDEXX LABORATORIES INC /DE

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 874716 ·
Last close
$690.24
Market Cap
$54.38B
52W High
$769.98
52W Low
$500.61
ADV30
651,209
Next earnings
2027-02-01

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 1,216,585,000 779,087,000 425,566,000 338,412,000 3,442,335,000 196,933,000 1,829,760,000
Mar 2026 1,140,820,000 722,739,000 362,586,000 278,446,000 3,385,497,000 200,528,000 1,829,394,000
Dec 2025 1,090,579,000 658,114,000 315,605,000 248,188,000 3,350,759,000 180,070,000 1,745,376,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,418,887,000
Investing CF
$-335,270,000
Financing CF
$-1,093,168,000
CapEx
$-118,886,000
Dividends Paid
—
Buybacks
$-1,047,788,000
EPS Diluted TTM
$14.83
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$7,325,905,000
Inventory
$390,874,000
Receivables
$721,318,000
ST Investments
—
EBIT TTM
$1,513,565,000
Pretax Income TTM
$1,478,973,000
Interest Exp TTM
$34,592,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,662,220,800
EBITDA
$1,673,122,944
Free Cash Flow
$1,064,129,600
Enterprise Value
$54,038,093,824
Total Cash
$197,536,000
Total Debt
$972,963,008
Shares Out
78,786,265
Trailing EPS
$14.84
Book Value
$23.72
ROE
68.9%
ROA
26.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,303,702,000 1,360,031,000 1,059,464,000 3,350,759,000 1,745,376,000 1,605,383,000 1,181,805,000
Dec 2024 3,897,504,000 1,128,337,000 887,867,000 3,293,443,000 1,698,130,000 1,595,313,000 929,001,000
Dec 2023 3,660,953,000 1,097,128,000 845,042,000 3,259,925,000 1,775,395,000 1,484,530,000 906,510,000
Dec 2022 3,367,324,000 898,765,000 679,089,000 2,746,765,000 2,138,028,000 608,737,000 542,984,000

TTM Snapshot

Revenues TTM
$4,553,223,000
NetIncome TTM
$1,139,656,000
OpCashFlow TTM
—
Assets (Latest)
$3,442,335,000
Forward EPS
$16.88

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $600.00 · spot: $698.47 · call volume: 80 · put volume: 420
Expected Move to 2026-12-18: ±$58.40 (8.36%) — implied range $640.07 – $756.87 · ATM straddle on $700.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IQV IQVIA HOLDINGS INC. $42.45B $257.60 —
INCY INCYTE CORP $24.27B $119.09 —
MEDP Medpace Holdings, Inc. $18.27B $653.09 —
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. $15.92B $332.16 —
ICLR ICON PLC $15.05B $195.02 —

News headlines (Yahoo Finance, 1h cache)

3 Stocks Rallying After Strong Q3 Earnings and Raised Guidance
2026-11-17 19:13 · Yahoo
How IDEXX Stock Is Engineered To Make Money For You
2026-11-07 01:10 · Yahoo
3 Reasons Growth Investors Will Love Idexx (IDXX)
2026-11-06 16:45 · Yahoo
IDEXX Laboratories (IDXX) Q3 Earnings Leave Its Premium Valuation In Focus
2026-11-03 23:22 · Yahoo
Idexx Laboratories (IDXX) Crossed Above the 200-Day Moving Average: What That Means for Investors
2026-11-03 13:30 · Yahoo
Company News for Nov 3, 2026
2026-11-03 13:22 · Yahoo
Top Stock Reports for Merck, Caterpillar & Union Pacific
2026-11-18 20:27 · Yahoo
Should You Continue to Hold Charles River Stock in Your Portfolio?
2026-11-18 13:47 · Yahoo
Should You Continue to Hold Medtronic Stock in Your Portfolio?
2026-11-18 12:22 · Yahoo
Invesco S&P 500 Equal Weight (RSP) Buys $0.7 Million More PTC on Nov. 16
2026-11-18 11:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.